Vitamin K2 - MK7 contributes to the prevention of calcium deposition in blood vessels and affects the breakdown of pre-existing calcifications. Vitamin K2-MK7 in ARTEROprotect® is obtained by a patented biofermentation process that provides a high yield of natural vitamin K2. Enhanced technology, which includes selective extraction and purification processes, guarantees the production of the all-trans, bioactive form of vitamin K2-MK7, in an extremely high percentage (> 99%).

Only one capsule of ARTEROprotect® daily provides 10 mg of Monacolin K, which has been shown to reduce LDL and total cholesterol levels. Monacolin K (a natural statin) has been approved by the European Food Safety Authority as an ingredient that can help maintain normal LDL cholesterol levels. Numerous studies have shown that Monacolin K, present in fermented red rice, can significantly reduce total and so-called 'bad', or LDL cholesterol. Monacolin K has been extensively investigated and has been shown to be effective in reducing triglycerides and reducing the risk of heart disease and stroke.

A recent clinical study submitted to the European Food Safety Authority (EFSA) shows that taking 7.5 mg of Monacolin K daily for 12 weeks can reduce LDL cholesterol levels by up to 22%. A total of 83 subjects with elevated cholesterol participated in the study. 42 subjects received a daily dose of about 7.5 mg Monacolin K. In the placebo group, 41 subjects took capsules with plain rice powder. After 12 weeks, the results of the Monacolin K group showed a 22% reduction in LDL (bad) cholesterol compared to only a 3% reduction in the placebo group. Total cholesterol is also effectively reduced.